Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells.
Journal - Cancer research (United States )
Although originating from a human breast cancer, BT-20 cells do not form colonies in soft agar. BT-20 cells do not express insulin receptor substrate-1 (IRS-1), which is known to promote both normal and abnormal growth and to inhibit differentiation. Stable expression of IRS-1 confers to BT-20 cells the ability to form colonies in soft agar. BT-20 cells form tumors in xenografts in mice, but the size of tumors is twice as large when the cells express IRS-1. The increased transformed phenotype is characterized by occupancy of the rDNA and cyclin D1 promoters by IRS-1 and the activation of the cyclin D1, c-myc, and rDNA promoters. In addition, the retinoblastoma protein, which is detectable in the rDNA promoter of quiescent BT-20/IRS-1 cells, is replaced by IRS-1 after insulin-like growth factor-I stimulation. Our results indicate that in BT-20 human mammary cancer cells, expression of IRS-1 activates promoters involved in cell growth and cell proliferation, resulting in a more transformed phenotype. Targeting of IRS-1 could be effective in inhibiting the proliferation of mammary cancer cells.
|ISSN : ||0008-5472|
|Mesh Heading : ||Animals Breast Neoplasms Chromatin Immunoprecipitation Female Genes, bcl-1 Genes, myc Humans Insulin Receptor Substrate Proteins Mice Mice, Nude Neoplasm Transplantation Phenotype Phosphoproteins Promoter Regions, Genetic Retinoblastoma Protein genetics physiology genetics|
|Mesh Heading Relevant : ||Cell Transformation, Neoplastic pathology physiology|